Exclusive articles:
Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio
Jyong Biotech Ltd. (Nasdaq stock code: MENS) (hereinafter referred to as “the Company” or “Jyong Biotech”) is a science-driven biotechnology company dedicated to developing...
CytoMed Therapeutics Ltd — An Emerging Star in Singapore’s Cancer Biotechnology Sector
In February 2026, The Wall Street Transcript published an exclusive interview with CytoMed Therapeutics Ltd (NASDAQ: GDTC) Chairman Choo Chee Kong. The interview covered the...
STARPATH GLOBAL: China’s Commercial Space Industry Reaches Its “TEMU Moment”
Shanghai, China — Satellites have traditionally been among the world’s most expensive assets. Building, launching, and operating a spacecraft often required investments measured in...
